Dr. Amin Herati

Dr. Amin Herati
Dr. Herati is a urologist with fellowship training in male infertility and andrology. He has specialized training to perform complex reconstructions of the reproductive system, including vasectomy reversal with vasovasostomy and vasoepididymostomy. Additionally, he has an interest in treating patients with chronic prostatitis and pelvic pain, as well as patients experiencing low testosterone, erectile dysfunction, Peyronie’s disease and benign prostatic hyperplasia (BPH). Of note, he has the ability to perform fertility treatments on patients who have experienced spinal cord injuries using nonsurgical methods of sperm extraction. Dr. Herati believes in an individualized approach to care that addresses the whole patient. He invests significant time into building a rapport with his patients so that they feel comfortable opening up about these issues, allowing him to accurately identify and manage each patient’s needs. His research interests include decoding the genetic basis of male infertility, investigating the impact of referred pain from peripheral nerves to the bladder, and characterizing the effects of low testosterone on prostate inflammation and PSA screening.

Languages Spoken:

English, Farsi, Spanish

Medical School:

University of Missouri-Kansas City School of Medicine

Residency:

Long Island Jewish Medical Center

Fellowship:

Urology and Molecular and Cellular Biology; Baylor College of Medicine

Locations

Johns Hopkins Medicine Lutherville, Maryland

10803 Falls Road Pavilion III, Suite 3300Lutherville, Maryland, 21093United States
410-616-7600 | Visit Website

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only